Form 4 for PYXS Pyxis Oncology, Inc.
Accepted 2023-09-22 00:00:00 ET · period of report 2023-09-22 · accession 0001209191-23-050433 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-09-22 | 2023-09-22 | PYXS | Wadhane Jitendra | CAO | P - Purchase | $1.74 | +2,500 | 219.4K | +1% | +$4,350 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-09-22 | P | A | 2,500 | $1.74 | 219,437 | D | — | — | (F1) The Reporting Person purchased all 2,500 shares of common stock in the open market at a price of $1.7397 per share. |